CAS No. |
152-62-5 |
中文名称 |
(8S,9R,10S,13S,14S,17S)-17-乙酰基-10,13-二甲基-1,2,8,9,10,11,12,13,14,15,16,17-十二氢-3H-环戊二烯并[a]菲-3-酮 |
英文名称 |
(8S,9R,10S,13S,14S,17S)-17-Acetyl-10,13-dimethyl-1,2,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
别名 |
DYDROGESTERONE [ORANGE BOOK] | HMS2097G03 | s4097 | .DELTA.6-Retroprogesterone | Prestwick2_000671 | 9-beta,10-alpha-Pregna-4,6-diene-3,20-dione | 9-beta,10alpha-Pregna-4,6-diene-3,20-dione | 9beta,10alpha-Pregna-4,6-diene-3,20-dione | DYDROGESTERONE [EP |
标准英文名 |
(8S,9R,10S,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
MDL No. |
MFCD00867864 |
分子式 |
C21H28O2 |
分子量 |
312.45
|
精确分子量 |
312.21
|
SMILES |
CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C |
标准SMILES |
CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@@]21C |
用途 |
Dydrogesterone is an orally active progestogen used for the treatment of conditions associated with endogenous progesterone deficiency, including: threatened or habitual abortion due to progesterone insufficiency; infertility caused by luteal phase defect; dysmenorrhea; endometriosis; secondary amenorrhea; irregular menstrual cycles; dysfunctional uterine bleeding; and premenstrual syndrome. It induces a complete secretory transformation of the endometrium in estrogen-primed uterus and exhibits pregnancy-protective immunomodulatory effects, such as reducing stress-induced miscarriage rates, modulating uterine immune cell populations (e.g., increasing IL-4+ and CD8+ cells), and elevating plasma progesterone-induced blocking factor (PIBF) levels without altering systemic progesterone concentrations. |
InChIKey |
JGMOKGBVKVMRFX-HQZYFCCVSA-N |